Hassan R - National Institutes of Health
Mesothelioma Cancer Expert at National Institutes of Health, Bethesda, MD
Mesothelioma Cancer Expert - Hassan R - Current Listing of Published Papers
The following is a listing of research papers by Hassan R in the field of mesothelioma cancer.
| Hassan R, Alexander R. Nonpleural mesotheliomas: mesothelioma of the peritoneum, tunica vaginalis, and pericardium. Hematol Oncol Clin North Am. 2005 Dec;19(6):1067-87, vi. Pubmed 16325124 Laboratory of Molecular Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, 37 Convent Drive, Room 5116, Bethesda, MD 20892-4264, USA. [mail.nih.gov] |
| Hassan R, Bera T, Pastan I. Mesothelin: a new target for immunotherapy. Clin Cancer Res. 2004 Jun 15;10(12 Pt 1):3937-42. Pubmed 15217923 Laboratory of Molecular Biology, National Cancer Institute, NIH, Bethesda, Maryland, USA. [mail.nih.gov] |
| Hassan R, Remaley AT, Sampson ML, Zhang J, Cox DD, Pingpank J, Alexander R, Willingham M, Pastan I, Onda M. Detection and quantitation of serum mesothelin, a tumor marker for patients with mesothelioma and ovarian cancer. Clin Cancer Res. 2006 Jan 15;12(2):447-53. Pubmed 16428485 Laboratory of Molecular Biology, Center for Cancer Research, National Cancer Institute/NIH, 37 Convent Drive, Bethesda, MD 20892, USA. [mail.nih.gov] |
| Antman K, Hassan R, Eisner M, Ries LA, Edwards BK. Update on malignant mesothelioma. Oncology (Williston Park). 2005 Sep;19(10):1301-9; discussion 1309-10, 1313-6. Pubmed 16285225 Provost, Boston University Medical Campus Dean, Boston University School of Medicine, Boston, Massachusetts 02118, USA. [bu.edu] |
| Ho M, Hassan R, Zhang J, Wang QC, Onda M, Bera T, Pastan I. Humoral immune response to mesothelin in mesothelioma and ovarian cancer patients. Clin Cancer Res. 2005 May 15;11(10):3814-20. Pubmed 15897581 Laboratory of Molecular Biology, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, Maryland, USA. |
| Li Q, Verschraegen CF, Mendoza J, Hassan R. Cytotoxic activity of the recombinant anti-mesothelin immunotoxin, SS1(dsFv)PE38, towards tumor cell lines established from ascites of patients with peritoneal mesotheliomas. Anticancer Res. 2004 May-Jun;24(3a):1327-35. Pubmed 15274292 Department of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA. |
| Hassan R, Viner JL, Wang QC, Margulies I, Kreitman RJ, Pastan I. Anti-tumor activity of K1-LysPE38QQR, an immunotoxin targeting mesothelin, a cell-surface antigen overexpressed in ovarian cancer and malignant mesothelioma. J Immunother. 2000 Jul-Aug;23(4):473-9. Pubmed 10916757 Laboratory of Molecular Biology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, USA. |
